tiprankstipranks
Advertisement
Advertisement

HK:1276 Stock Latest News

Hengrui Pharma Wins NMPA Nod for New Autoimmune Indication of Innovative Drug
Company AnnouncementsHengrui Pharma Wins NMPA Nod for New Autoimmune Indication of Innovative Drug
8d ago
1276
Hengrui Wins First-in-China Anti-HER2 Approval for Colorectal Cancer
PremiumCompany Announcements
Hengrui Wins First-in-China Anti-HER2 Approval for Colorectal Cancer
8d ago
1276
Jiangsu Hengrui Board to Review Interim Results and Dividend in August
PremiumCompany Announcements
Jiangsu Hengrui Board to Review Interim Results and Dividend in August
8d ago
1276
Hengrui Pharma Wins First China Approval for Home-Grown Long-Acting Insulin Analog
PremiumCompany Announcements
Hengrui Pharma Wins First China Approval for Home-Grown Long-Acting Insulin Analog
16d ago
1276
Hengrui Wins NMPA Nod to Move Cervical Cancer Combo to First-Line Use
PremiumCompany Announcements
Hengrui Wins NMPA Nod to Move Cervical Cancer Combo to First-Line Use
22d ago
1276
Hengrui Pharma Wins NMPA Approval for First 0.1% Water-Free Cyclosporine Eye Drop in China
PremiumCompany AnnouncementsHengrui Pharma Wins NMPA Approval for First 0.1% Water-Free Cyclosporine Eye Drop in China
2M ago
1276
Hengrui Wins Landmark NMPA Nod for New Lung Cancer Use of PD-L1 Drug
Premium
Company Announcements
Hengrui Wins Landmark NMPA Nod for New Lung Cancer Use of PD-L1 Drug
2M ago
1276
Hengrui Pharma Wins NMPA Nod for New Dalpiciclib Breast Cancer Indication
Premium
Company Announcements
Hengrui Pharma Wins NMPA Nod for New Dalpiciclib Breast Cancer Indication
2M ago
1276
Hengrui Pharma Wins NMPA Approval for First Domestic New-Generation URAT1 Inhibitor
PremiumCompany Announcements
Hengrui Pharma Wins NMPA Approval for First Domestic New-Generation URAT1 Inhibitor
3M ago
1276
Hengrui Pharma seals global collaboration and licensing deal with Bristol-Myers Squibb
PremiumCompany Announcements
Hengrui Pharma seals global collaboration and licensing deal with Bristol-Myers Squibb
3M ago
1276
Hengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
PremiumCompany Announcements
Hengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
4M ago
1276
Hengrui Pharma Sets Nomination Committee to Tighten Board Governance
PremiumCompany Announcements
Hengrui Pharma Sets Nomination Committee to Tighten Board Governance
4M ago
1276
Hengrui Pharma Assumes KiOmed License from Hansoh in Connected Deal
PremiumCompany AnnouncementsHengrui Pharma Assumes KiOmed License from Hansoh in Connected Deal
4M ago
1276
Jiangsu Hengrui Sets Detailed Mandate for Board Audit Committee
Premium
Company Announcements
Jiangsu Hengrui Sets Detailed Mandate for Board Audit Committee
4M ago
1276
Hengrui Pharmaceuticals Posts Double-Digit Profit Growth in Strong Q1 2026
Premium
Company Announcements
Hengrui Pharmaceuticals Posts Double-Digit Profit Growth in Strong Q1 2026
4M ago
1276
Jiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
PremiumCompany Announcements
Jiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
4M ago
1276
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
PremiumCompany Announcements
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
4M ago
1276
Hengrui Pharma Shareholders Approve Dividends, Board Changes at 2025 AGM
PremiumCompany Announcements
Hengrui Pharma Shareholders Approve Dividends, Board Changes at 2025 AGM
4M ago
1276
Jiangsu Hengrui Outlines Board Composition and Key Governance Committees
PremiumCompany Announcements
Jiangsu Hengrui Outlines Board Composition and Key Governance Committees
4M ago
1276
Jiangsu Hengrui Schedules Board Meeting to Approve First-Quarter 2026 Results
PremiumCompany AnnouncementsJiangsu Hengrui Schedules Board Meeting to Approve First-Quarter 2026 Results
4M ago
1276
Jiangsu Hengrui Pharmaceuticals Publishes 2025 Audited Annual Results
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Publishes 2025 Audited Annual Results
5M ago
1276
Jiangsu Hengrui Pharmaceuticals Proposes Final 2025 Dividend
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Proposes Final 2025 Dividend
5M ago
1276

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >